Back
PLBY Group Vs. Kymera Therapeutics Industry Stock Comparison
Sell
25
PLBY
PLBY Group
Last Price:
0.58
Seasonality Move:
-7.96%
Buy
58
KYMR
Kymera Therapeutics
Last Price:
46.87
Seasonality Move:
25.63%
Sell
25
PLBY Group (PLBY)
is a Sell
Is PLBY Group a Buy, Sell or Hold?
- The current PLBY Group [PLBY] share price is $0.57. The Score for PLBY is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- PLBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $46.19. The Score for KYMR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PLBY Stock Price Chart
What is PLBY Group's stock price today?
-
The PLBY Group share price today is $0.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLBY is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $46.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
PLBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 42.21 | Sell |
Chaikin Money Flow: | 53456 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.53 - 0.69) | Sell |
Bollinger Bands (100): | (0.68 - 0.96) | Sell |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.16 | Buy |
Relative Strength Index (14 RSI): | 53.14 | Buy |
Chaikin Money Flow: | -53339 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.25 - 48.01) | Buy |
Bollinger Bands (100): | (32.65 - 44.29) | Buy |
PLBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.55 | Buy |
20-day SMA: | 0.58 | Sell |
50-day SMA: | 0.72 | Sell |
200-day SMA: | 0.89 | Sell |
8-day EMA: | 0.56 | Buy |
20-day EMA: | 0.6 | Sell |
50-day EMA: | 0.69 | Sell |
200-day EMA: | 0.99 | Sell |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.97 | Sell |
20-day SMA: | 46.18 | Buy |
50-day SMA: | 42.65 | Buy |
200-day SMA: | 35.44 | Buy |
8-day EMA: | 46.57 | Sell |
20-day EMA: | 45.95 | Buy |
50-day EMA: | 43.11 | Buy |
200-day EMA: | 36.01 | Buy |
PLBY Group Earnings Growth & PLBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and an increase next year of $0.20 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.51 per share.
PLBY Group Technical Analysis
Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |